17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?

被引：0
|
作者：
Hynes, Jenna S. [1 ]
Schwartz, Amanda R. [1 ]
Abdalla, Azza [1 ]
Manuck, Tracy A. [2 ]
Dotters-Katz, Sarah K. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, 201 Trent Dr, Durham, NC 27710 USA
[2] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM | 2021年 / 3卷 / 01期
关键词：
D O I：
10.1016/j.ajogmf.2020.100278
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] 17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should REPLY
    Combs, C. Andrew
    Garite, Thomas J.
    Das, Anita
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (05) : E17 - E17
  • [42] Fetal fibronectin and cervical length as predictors of preterm birth in twin pregnancies, with or without 17-hydroxyprogesterone caproate
    Combs, C. Andrew
    Garite, Thomas
    Maurel, Kimberly
    Das, Anita
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S205 - S205
  • [43] Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate
    Fukuda, Toma
    Kyozuka, Hyo
    Murata, Tsuyoshi
    Yasuda, Shun
    Yamaguchi, Akiko
    Fujimori, Keiya
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (09) : 3119 - 3126
  • [44] The Safety of Progesterone and 17-Hydroxyprogesterone Caproate Administration for the Prevention of Preterm Birth: An Evidence-Based Assessment
    O'Brien, John M.
    AMERICAN JOURNAL OF PERINATOLOGY, 2012, 29 (09) : 665 - 672
  • [45] Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate
    Szychowski, Jeff M.
    Berghella, Vincenzo
    Owen, John
    Hankins, Gary
    Iams, Jay D.
    Sheffield, Jeanne S.
    Perez-Delboy, Annette
    Wing, Deborah A.
    Guzman, Edwin R.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (12): : 2686 - 2689
  • [46] Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth
    Massa, Katherine
    Childress, Katherine
    Vricella, Laura K.
    Boerrigter, Ashley
    Franklin, Briana H. K.
    Sauer, Megan
    Armbruster, Raina
    Tomlinson, Tracy
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2020, 2 (04)
  • [47] Genetic variation and recurrent prematurity among women receiving 17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth
    Manuck, Tracy A.
    Anglim, Laura
    Downes, Katheryne
    Elovitz, Michal A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S395 - S395
  • [48] Progesterone (17α-Hydroxyprogesterone Caproate) for Prevention of Preterm Birth and Preeclampsia
    Ngai, Ivan
    Sheen, Jean-Ju
    Garretto, Diana
    Govindappagari, Shravya
    Bernstein, Peter
    Garry, David J.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 162S - 162S
  • [49] 17 alpha-hydroxyprogesterone caproate, HIV, and preterm birth
    Ntozini, Robert
    Prendergast, Andrew J.
    LANCET HIV, 2021, 8 (10): : E600 - E601
  • [50] The Effect of 17α-Hydroxyprogesterone Caproate on Preterm Birth in Women with an Ultrasound-Indicated Cerclage
    Rafael, Timothy J.
    Mackeen, A. Dhanya
    Berghella, Vincenzo
    AMERICAN JOURNAL OF PERINATOLOGY, 2011, 28 (05) : 389 - 393
12345